<SEC-DOCUMENT>0001575872-20-000043.txt : 20200227
<SEC-HEADER>0001575872-20-000043.hdr.sgml : 20200227
<ACCEPTANCE-DATETIME>20200227073632
ACCESSION NUMBER:		0001575872-20-000043
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20200227
FILED AS OF DATE:		20200227
DATE AS OF CHANGE:		20200227

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DR REDDYS LABORATORIES LTD
		CENTRAL INDEX KEY:			0001135951
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-15182
		FILM NUMBER:		20658496

	BUSINESS ADDRESS:	
		STREET 1:		8-2-337, ROAD NO.3 BANJARA HILLS
		CITY:			HYDERABAD
		STATE:			K7
		ZIP:			500-034
		BUSINESS PHONE:		91 40 49002900

	MAIL ADDRESS:	
		STREET 1:		8-2-337, ROAD NO.3 BANJARA HILLS
		CITY:			HYDERABAD
		STATE:			K7
		ZIP:			500-034
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>drr0195_6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt">SECURITIES
AND EXCHANGE COMMISSION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Form 6-K</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>REPORT
OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt">UNDER
THE SECURITIES EXCHANGE ACT OF 1934</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">February, 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Commission File Number 1-15182</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: bold 24pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="text-transform: none">DR.
REDDY&rsquo;S LABORATORIES LIMITED</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Translation of registrant&rsquo;s name
into English)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>8-2-337, Road No. 3, Banjara Hills</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Hyderabad, Telangana 500 034, India</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">+91-40-49002900</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive office)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant files or will
file annual reports under cover of Form 20-F or Form 40-F.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form 20-F&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Wingdings; font-size: 10pt">x</FONT></TD>
    <TD STYLE="width: 50%; text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form 40-F&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(1):&nbsp;______</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Note:</B> Regulation S-T Rule 101(b)(1) only permits the
submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(7):&nbsp;______</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Note: </B>Regulation S-T Rule 101(b)(7)
only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign
private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled
or legally organized (the registrant&rsquo;s &ldquo;home country&rdquo;), or under the rules of the home country exchange on which
the registrant&rsquo;s securities are traded, as long as the report or other document is not a press release, is not required to
be and has not been distributed to the registrant&rsquo;s security holders, and, if discussing a material event, has already been
the subject of a Form 6-K submission or other Commission filing on EDGAR.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether by furnishing
the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to
Rule 12g3-2(b) under the Securities Exchange Act of 1934.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD STYLE="width: 50%; text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Wingdings; font-size: 10pt">x</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If &ldquo;Yes&rdquo; is marked, indicate below the file number
assigned to registrant in connection with Rule 12g3-2(b): 82-________.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>EXHIBITS </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; width: 10%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: black 1pt solid"><B>Exhibit<BR>
        Number</B></P></TD>
    <TD STYLE="padding-bottom: 1pt; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; white-space: nowrap; width: 88%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description of Exhibits</B></FONT></TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR>
    <TD STYLE="white-space: nowrap; vertical-align: top"><A HREF="drr0195_ex99-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><A HREF="drr0195_ex99-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intimation dated February 27, 2020.</FONT></A></TD></TR>
<TR>
    <TD STYLE="white-space: nowrap; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD STYLE="white-space: nowrap; vertical-align: top"><A HREF="drr0195_ex99-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.2</FONT></A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><A HREF="drr0195_ex99-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press Release on &lsquo;Dr. Reddy's Laboratories announces the first generic launch of Naproxen and Esomeprazole Magnesium Delayed-Release Tablets in the U.S. Market&rsquo; dated February 27, 2020.</FONT></A></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>SIGNATURES </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: bottom">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">DR. REDDY&rsquo;S LABORATORIES LIMITED</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(Registrant)</P></TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: February 27, 2020</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; border-bottom: Black 1pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Sandeep Poddar</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; width: 50%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 4%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: </FONT></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sandeep Poddar</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: </FONT></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Secretary</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>drr0195_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0">&#8239;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 65%; font-size: 10pt"><IMG SRC="drr0195_img01.jpg" ALT="">&nbsp;</TD>
    <TD STYLE="width: 35%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Dr. Reddy&rsquo;s Laboratories Ltd.</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>8-2-337, Road No. 3, Banjara Hills,</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Hyderabad - 500 034, Telangana, India.</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>CIN : L85195TG1984PLC004507</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Tel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;:+91 40 4900 2900</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Fax &nbsp;&nbsp;&nbsp;&nbsp;:+91 40 4900 2999</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Email :mail@drreddys.com</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>www.drreddys.com</B></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">February 27, 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate Relationship Department</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">National Stock Exchange of India Ltd.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BSE Limited</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Exchange Plaza&rdquo;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dalal Street, Fort</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bandra-Kurla Complex, Bandra (East),</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Mumbai &ndash; 400 001</U></FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mumbai &ndash; 400 051</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fax Nos.: 022-22723121 / 22723719 /</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fax Nos.: 022-26598120/ 26598237/</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 40pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22722037 / 22722039</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 40pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26598238</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Scrip Code: 500124</U></B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Scrip Code: DRREDDY-EQ</U></B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Sirs,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Sub: Intimation</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This is to inform you that the audit of
our Integrated Product Development Organization (IPDO) at Medchal-Malkajgiri, Telangana, by the US FDA, has been completed today,
and no Form 483 was issued at the closure of the audit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This is for your information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">With regards,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Sandeep Poddar</FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sandeep Poddar</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Secretary</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">CC:- New York Stock Exchange Inc.(Stock Code :RDY)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>drr0195_ex99-2.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 99.2</B></P>

<P STYLE="text-align: right; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 67%; font-size: 10pt"><IMG SRC="drr0195_img01.jpg" ALT="">&nbsp;</TD>
    <TD STYLE="width: 33%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Dr. Reddy&rsquo;s Laboratories Ltd.</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>8-2-337, Road No. 3, Banjara Hills,</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Hyderabad - 500 034, Telangana, India.</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>CIN : L85195TG1984PLC004507</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Tel &nbsp;&nbsp;&nbsp;&nbsp;:+91 40 4900 2900</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Fax &nbsp;&nbsp;&nbsp;&nbsp;:+91 40 4900 2999</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Email :mail@drreddys.com</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>www.drreddys.com</B></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">February 27, 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate Relationship Department</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">National Stock Exchange of India Ltd.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BSE Limited</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Exchange Plaza&rdquo;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dalal Street, Fort</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bandra-Kurla Complex, Bandra (East),</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Mumbai &ndash; 400 001</U></FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Mumbai &ndash; 400 051</U></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fax Nos.: 022-22723121 / 22723719 /</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fax Nos.: 022-26598120/ 26598237/</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;22722037 / 22722039</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26598238</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Scrip Code: 500124</U></B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Scrip Code: DRREDDY-EQ</U></B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Sirs,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Sub: <U>Press Release</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Please find enclosed a Press Release on &ldquo;Dr. Reddy's Laboratories
announces the first generic launch of Naproxen and Esomeprazole Magnesium Delayed-Release Tablets in the U.S. Market&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This is for your information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">With regards,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Sandeep Poddar</FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sandeep Poddar</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Secretary</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Encl: As above</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">CC: New York Stock Exchange (Stock Code: RDY)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="drr0195_img03.jpg" ALT="">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="text-transform: uppercase"><B>CONTACT</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DR. REDDY'S LABORATORIES LTD.</B></FONT></TD>
    <TD STYLE="width: 25%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Investor relationS</B></FONT></TD>
    <TD STYLE="width: 25%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Media relationS</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-2-337, Road No. 3, Banjara Hills, <BR>
Hyderabad - 500034. Telangana, India.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">AMIT AGARWAL </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>amita@drreddys.com
    </U><FONT STYLE="text-transform: uppercase"><BR>
    (Ph: +91-40-49002135)</FONT></FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase">Deep GHATAK</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>deepghatak@drreddys.com</U></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase">(Ph: +91-40- 49002121)</FONT></P></TD></TR>
</TABLE>
<P STYLE="border-bottom: Black 1pt solid; text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: -4.5pt"><FONT STYLE="font-size: 12pt"><B>Dr.
Reddy's Laboratories announces the first generic launch of Naproxen and Esomeprazole Magnesium Delayed-Release Tablets in the
U.S. Market</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Hyderabad, India, February 27, 2020</B></FONT></TD>
    <TD STYLE="width: 50%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For Immediae Release</B></FONT></TD></TR>
</TABLE>
<P STYLE="border-bottom: Black 1pt solid; text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Hyderabad, India and Princeton, NJ, USA. February 27, 2020 &mdash;
Dr. Reddy&rsquo;s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as
&ldquo;Dr. Reddy&rsquo;s&rdquo;) today announced the first-to-market launch of Naproxen and Esomeprazole Magnesium Delayed-Release
Tablets, a therapeutic equivalent generic version of Vimovo<SUP>&reg;</SUP> (Naproxen and Esomeprazole Magnesium) Delayed-Release
Tablets approved by the U.S. Food and Drug Administration (USFDA).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;This launch is a testament to our core strengths in areas
of research and development and intellectual property,&rdquo; says Marc Kikuchi, Chief Executive Officer, North America Generics.
&ldquo;We are excited to be a part of forming the first generic market for Vimovo<SUP>&reg; </SUP>Tablets and to provide an affordable
treatment alternative for patients.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Vimovo<SUP>&reg;</SUP> (Naproxen and Esomeprazole Magnesium)
Delayed-Release Tablets brand had U.S. sales of approximately $414 million MAT for the most recent twelve months ending in December
2019 according to IQVIA Health*.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dr. Reddy&rsquo;s Naproxen and Esomeprazole Magnesium Delayed-Release
Tablets are available in 375 mg/20 mg and 500 mg/20 mg tablets in bottle count sizes of 60.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>WARNING: RISK OF SERIOUS CARDIOVASCULAR AND GASTROINTESTINAL
EVENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Cardiovascular Thrombotic Events</U></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Non-Steroidal Anti-inflammatory Drugs (NSAIDs), a component of
naproxen and esomeprazole magnesium delayed-release tablets, cause an increased risk of serious cardiovascular thrombotic events,
including myocardial infarction and stroke, which can be fatal. This risk may occur early in treatment and may increase with duration
of use.</B></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Naproxen and esomeprazole magnesium delayed-release tablets are
contraindicated in the setting of coronary artery bypass graft (CABG) surgery.</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Gastrointestinal Bleeding, Ulceration, and Perforation</U></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>NSAIDs, a component of naproxen and esomeprazole magnesium delayed-release
tablets cause an increased risk of serious gastrointestinal (GI) adverse events including bleeding, ulceration, and perforation
of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. Elderly
patients and patients with a prior history of peptic ulcer disease and/or GI bleeding are at greater risk for serious GI events.</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Please see</B> the full prescribing information including
boxed warning as well as medicatin guide.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>https://www.drreddys.com/pi/naproxen-eso-leaflet.pdf</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>https://www.drreddys.com/pi/naproxen-eso-mg.pdf</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Vimovo&reg; is a trademark of Horizon&nbsp;PharmaMedicines LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="drr0195_img02.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8.8pt 0pt 0">*IQVIA Retail and Non-Retail MAT December 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">RDY-1019-264</P>

<P STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8.8pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8.8pt 0pt 0"><B>About Dr. Reddy&rsquo;s</B>: Dr. Reddy&rsquo;s
Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) is an integrated pharmaceutical company, committed to providing affordable
and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services &amp; Active Ingredients,
Global Generics and Proprietary Products &ndash; Dr. Reddy&rsquo;s offers a portfolio of products and services including APIs,
custom pharmaceutical services, generics, biosimilars and differentiated formulations. Our major therapeutic areas of focus are
gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Dr. Reddy&rsquo;s operates in markets
across the globe. Our major markets include &ndash; USA, India, Russia &amp; CIS countries, and Europe. For more information,
log on to: <U>www.drreddys.com</U></P>

<P STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8.8pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8.8pt 0pt 0"><B>Disclaimer</B>: This press release may include
statements of future expectations and other forward-looking statements that are based on the management&rsquo;s current views and
assumptions and involve known or unknown risks and uncertainties that could cause actual results, performance or events to differ
materially from those expressed or implied in such statements. In addition to statements which are forward-looking by reason of
context, the words &quot;may&quot;, &quot;will&quot;, &quot;should&quot;, &quot;expects&quot;, &quot;plans&quot;, &quot;intends&quot;,
&quot;anticipates&quot;, &quot;believes&quot;, &quot;estimates&quot;, &quot;predicts&quot;, &quot;potential&quot;, or &quot;continue&quot;
and similar expressions identify forward-looking statements. Actual results, performance or events may differ materially from those
in such statements due to without limitation, (i) general economic conditions such as performance of financial markets, credit
defaults , currency exchange rates , interest rates , persistency levels and frequency / severity of insured loss events (ii) mortality
and morbidity levels and trends, (iii) changing levels of competition and general competitive factors, (iv) changes in laws and
regulations and in the policies of central banks and/or governments, (v) the impact of acquisitions or reorganization , including
related integration issues.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8.8pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8.8pt 0pt 0">The company assumes no obligation to update any information
contained herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8.8pt 0pt 0">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 8.8pt 0pt 0">&nbsp;<IMG SRC="drr0195_img02.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8.8pt 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>drr0195_img01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 drr0195_img01.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ *P#' P$1  (1 0,1 ?_$ *L   $#! ,!
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MC[0W8"(]%O[RPJK!PLD >*B0J::G.)N)N4("]MJGZS, ^ E%OM*O'(I1G;<
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H/N:[O^]D';1_IX_]<6ZJO 9*9:7\7_F;S\_,?/[^/,K(JN"(X(O_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>drr0195_img02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 drr0195_img02.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 9@!H P$1  (1 0,1 ?_$ *4   (" P # 0
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MQ%02?!L(9F8[+W5-%#TUT/\ BZQVZ3MC?MJN(S)>R0.>6EV+"PJTZ?\ 20@
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0G<6_&I.ASG0ISK-8K%?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>drr0195_img03.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 drr0195_img03.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 10+1 P$1  (1 0,1 ?_$ ,4  0 " @(# 0$
M       ("08*!0<!! L" P$!  $% 0$!              4"! 8'" ,!"1
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MX_"WL2@P"<X=_=G3Y!9WU/CV_MQ^%O8E!@$YP[^[.GR"SOJ?'M_;C\+>Q*#
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M)N%,M/<221ECV\JU,2'"W,P] L-*<P;:<[0EI=725J"31'"4D7$<,1 1E"L
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MORE#9<P8LE>0(3FO)&2,U*XZ7*10^31UUFD;;Y0_LY0RE3^VXPC\;3&EMHS
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M_I_Y_P!_?&[^WJ5WVR:&;;W+-/7*DN1\<PJ=XWBFXY[<Y,2ZQ9GD8[L+5 )
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M6N9PZ.N7[TMHV!P9)R5WV-NA$XG=;4EE'4%6F@"L1D$C6&%ER\6[CM;3E_\
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M19UD8"7_ -1<@_\ ,*/_ !U,/^QEW_\ ,;E^W[^W&HS*"_\ I%IL'_2P\_\
MZ;?_  JB.OIM_A'ZOP6&Z$OB5'DB_7U(U?@.GRJO;AU]R:$OB5'DB_7TJ_ =
M/E3;AU]R:$OB5'DB_7TJ_ =/E3;AU]R:$OB5'DB_7TJ_ =/E3;AU]R:$OB5'
MDB_7TJ_ =/E3;AU]R:$OB5'DB_7TJ_ =/E3;AU]R:$OB5'DB_7TJ_ =/E3;A
MU]R:$OB5'DB_7TJ_ =/E3;AU]R:$OB5'DB_7TJ_ =/E3;AU]R:$OB5'DB_7T
MJ_ =/E3;AU]R:$OB5'DB_7TJ_ =/E3;AU]R:$OB5'DB_7TJ_ =/E3;AU]R:$
MOB5'DB_7TJ_ =/E3;AU]R:$OB5'DB_7TJ_ =/E3;AU]R:$OB5'DB_7TJ_ =/
ME3;AU]R:$OB5'DB_7TJ_ =/E3;AU]R:$OB5'DB_7TJ_ =/E3;AU]R:$OB5'D
MB_7TJ_ =/E3;AU]R:$OB5'DB_7TJ_ =/E3;AU]R:$OB5'DB_7TJ_ =/E3;AU
M]R:$OB5'DB_7TJ_ =/E3;AU]R:$OB5'DB_7TJ_ =/E3;AU]R:$OB5'DB_7TJ
M_ =/E3;AU]R:$OB5'DB_7TJ_ =/E3;AU]R:$OB5'DB_7TJ_ =/E3;AU]R:$O
MB5'DB_7TJ_ =/E3;AU]R:$OB5'DB_7TJ_ =/E3;AU]R:$OB5'DB_7TJ_ =/E
M3;AU]R:$OB5'DB_7TJ_ =/E3;AU]R:$OB5'DB_7TJ_ =/E3;AU]R:$OB5'DB
M_7TJ_ =/E3;AU]R:$OB5'DB_7TJ_ =/E3;AU]R:$OB5'DB_7TJ_ =/E3;AU]
MR:$OB5'DB_7TJ_ =/E3;AU]R:$OB5'DB_7TJ_ =/E3;AU]R:$OB5'DB_7TJ_
M =/E3;AU]R:$OB5'DB_7TJ_ =/E3;AU]R:$OB5'DB_7TJ_ =/E3;AU]R:$OB
M5'DB_7TJ_ =/E3;AU]R:$OB5'DB_7TJ_ =/E3;AU]R:$OB5'DB_7TJ_ =/E3
M;AU]R:$OB5'DB_7TJ_ =/E3;AU]R:$OB5'DB_7TJ_ =/E3;AU]R:$OB5'DB_
M7TJ_ =/E3;AU]R:$OB5'DB_7TJ_ =/E3;AU]R:$OB5'DB_7TJ_ =/E3;AU]R
M:$OB5'DB_7TJ_ =/E3;AU]R:$OB5'DB_7TJ_ =/E3;AU]R:$OB5'DB_7TJ_
M=/E3;AU]R:$OB5'DB_7TJ_ =/E3;AU]R:$OB5'DB_7TJ_ =/E3;AU]R:$OB5
M'DB_7TJ_ =/E3;AU]R:$OB5'DB_7TJ_ =/E3;AU]R:$OB5'DB_7TJ_ =/E3;
MAU]R:$OB5'DB_7TJ_ =/E3;AU]R:$OB5'DB_7TJ_ =/E3;AU]R:$OB5'DB_7
MTJ_ =/E3;AU]R:$OB5'DB_7TJ_ =/E3;AU]R:$OB5'DB_7TJ_ =/E3;AU]R:
M$OB5'DB_7TJ_ =/E3;AU]R:$OB5'DB_7TJ_ =/E3;AU]R:$OB5'DB_7TJ_ =
M/E3;AU]R:$OB5'DB_7TJ_ =/E3;AU]R:$OB5'DB_7TJ_ =/E3;AU]R:$OB5'
MDB_7TJ_ =/E3;AU]R:$OB5'DB_7TJ_ =/E3;AU]R:$OB5'DB_7TJ_ =/E3;A
MU]R:$OB5'DB_7TJ_ =/E3;AU]R:$OB5'DB_7TJ_ =/E3;AU]R:$OB5'DB_7T
MJ_ =/E3;AU]R:$OB5'DB_7TJ_ =/E3;AU]R:$OB5'DB_7TJ_ =/E3;AU]R:$
MOB5'DB_7TJ_ =/E3;AU]R:$OB5'DB_7TJ_ =/E3;AU]R:$OB5'DB_7TJ_ =/
ME3;AU]R:$OB5'DB_7TJ_ =/E3;AU]R:$OB5'DB_7TJ_ =/E3;AU]R:$OB5'D
MB_7TJ_ =/E3;AU]R:$OB5'DB_7TJ_ =/E3;AU]R:$OB5'DB_7TJ_ =/E3;AU
M]R:$OB5'DB_7TJ_ =/E3;AU]R:$OB5'DB_7TJ_ =/E3;AU]R:$OB5'DB_7TJ
M_ =/E3;AU]R:$OB5'DB_7TJ_ =/E3;AU]R:$OB5'DB_7TJ_ =/E3;AU]R:$O
MB5'DB_7TJ_ =/E3;AU]R:$OB5'DB_7TJ_ =/E3;AU]R:$OB5'DB_7TJ_ =/E
I3;AU]R:$OB5'DB_7TJ_ =/E3;AU]R:$OB5'DB_7TJ_ =/E3;AU]R_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
